TeleRare Health® Successfully Completes SOC 2® Type I Examination
Independent examination reinforces the TeleRare Health® commitment to protecting sensitive healthcare information
EAGAN, Minn., September 21, 2026. TeleRare Health, today announced that it has successfully completed its System and Organization Controls (SOC) 2® Type I examination and received its independent service auditor’s report.
The examination evaluated whether the controls described in the TeleRare Health platform were suitably designed to meet the applicable Trust Services Criteria established by the American Institute of Certified Public Accountants.
The successful completion of the examination represents an important milestone in the continued investment by TeleRare Health in information security, risk management, and the responsible handling of sensitive healthcare information.
“Patients, healthcare professionals and organizational partners need to trust TeleRare Health with sensitive and important information,” said Patti Engel, Co-Founder and President. “Completing our SOC 2 Type I examination demonstrates that security is built into every aspect of our mission and operations, reflecting our commitment to protect the privacy of people affected by rare and genetic conditions.”
The examination was conducted by Advantage Partners, an independent certified public accounting firm.
The independent service auditor issued a clean opinion, with no exceptions noted, regarding the suitability of the design of TeleRare Health’s controls as of the examination date.
TeleRare Health will continue to evaluate, monitor and strengthen its information-security program as the company expands its technology enabled genomic platform and expert services.
About TeleRare Health
TeleRare Health’s mission is to address the longstanding problem of fragmented rare disease care, by providing the clinical infrastructure and smart technology needed to help you orchestrate genomic-informed care. By integrating our expert clinicians and smart technology, TeleRare health assists health systems to make coordinated, lifelong genomic care accessible to all patients.
For more information, visit www.telerare.com
Media Contact
Stacy Pike-Langenfeld
SOC 2® is a registered trademark of the American Institute of Certified Public Accountants.
Comments